SCHEMBL12891767

SCHEMBL12891767

C/C=C1\C[C@H](C)CN([C@@H](C)c2ccc(F)cc2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 9/20 0.40
PSEN1 P49768 3/20 0.38
PSEN2 P49810 3/20 0.38
APH1B Q8WW43 3/20 0.38
NCSTN Q92542 3/20 0.38
APH1A Q96BI3 3/20 0.38
PSENEN Q9NZ42 3/20 0.38
CYP3A4 P08684 3/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12891770 1.00 HSD11B1 (0.40) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL14870541 0.78 PSEN1 (0.47) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL14870537 0.76 PSEN1 (0.56) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL4330555 0.71 HSD11B1 (0.45) HSD11B1CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL13434491 0.70 OPRM1 (0.33) HSD11B1KCNH2
SCHEMBL13434490 0.70 OPRM1 (0.33) HSD11B1KCNH2
SCHEMBL12891947 0.68 HSD11B1 (0.36) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL12891958 0.67 HSD11B1 (0.38) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL9939512 0.65 KMT2A (0.66) HSD11B1ALDH1A1KMT2A
SCHEMBL9938489 0.65 KMT2A (0.66) HSD11B1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7880009-B2 Alzheimer's disease, senile dementia, Down syndrome or amyloidosis; (E)-N-biphenyl-3-ylmethyl-3-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)acrylamide for example; imidazolyl-functional compounds inhibit production of Amyloid beta 40 and Amyloid beta 42 EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-02-01 US disclosed